Misco Products introduced AG24 this week at ISSA/INTERCLEAN® North
America 2009. The product launch follows the completion of an agreement
with PURE Bioscience (NASDAQ:
PURE), a leader in nontoxic solutions for global health challenges,
for blending, packaging and distribution of PURE’s silver dihydrogen
citrate SDC-based disinfectant under the name AG24™.
Ben Gable, Product Manager for Misco Products Corporation, stated, “We
maintain a continuous commitment to bringing innovative products to our
customers and the marketplace, and we are excited to introduce our
newest disinfectant, AG24, here at ISSA as a key addition to our product
line. Last year’s ISSA show brought more than 16,000 visitors, most from
the janitorial supply industry, and featured more than 700 exhibitors.
The jan/san commercial and institutional markets are calling for
responsible products like AG24, and we believe we are positioned to fill
that need. AG24 provides clear advantages and benefits with its broad
spectrum efficacy, quick kill times and EPA Category IV toxicity rating.
The initial response here at the trade show has been terrifically
positive, and we expect our customers to quickly adopt AG24 into their
inventories.”
Michael L. Krall, President and CEO of PURE Bioscience, stated, “ISSA is
the largest worldwide cleaning-industry association, and its annual
North America trade show, especially with the new Green Connections
Center, is the premier venue for a product launch. With almost a half
century of chemical manufacturing and selling experience, Misco leads
the industry with a complete line of cleaning and maintenance products
marketed directly and through an established and sophisticated private
brand program. We are impressed with Misco’s aggressive product launch
strategy and look forward to a successful relationship and expanded
market reach for our SDC-based disinfectant.”
AG24 carries a 30-second kill time on Pseudomonas aeruginosa and Salmonella
enterica, a 24-hour residual kill on standard indicator bacteria, a
2-minute kill time on some resistant strains of bacteria, 10-minute kill
time on fungi, 30-second kill time on HIV Type I, and 3 to 10-minute
kill times on other pathogenic viruses including Human and Avian
Influenza A as well as Norovirus. These claims distinguish the efficacy
of AG24 from many of the leading commercial and consumer products
currently on the market, while maintaining lower toxicity ratings. Based
on the EPA toxicity ratings from Category I (high toxicity) down to
Category IV, AG24 is a Category IV antimicrobial for which hazard and
precautionary labeling statements are not required. This compares with
Category II warning statements for most leading brands of disinfectant
products.
About Misco Products Corporation
Founded in 1962, Misco Products Corporation is located in Reading,
Pennsylvania. By focusing on customer needs, MISCO has grown into a
company that offers a complete line of cleaning and maintenance products
and is “The Leader in Private Branding”. The mission of MISCO Products
is to prosper by valuing and delighting our customers and employees
through innovation, integrity and a dedication to excellence. Please
visit www.miscoproducts.com.
About PURE Bioscience
PURE Bioscience develops and markets technology-based bioscience
products that provide solutions to numerous global health challenges.
PURE's proprietary high efficacy/low toxicity bioscience technologies,
including its silver dihydrogen citrate-based antimicrobials, represent
innovative advances in diverse markets and lead today's global trend
toward industry and consumer use of "green" products while providing
competitive advantages in efficacy and safety. Patented SDC is an
electrolytically generated source of stabilized ionic silver which
formulates well with other compounds. As a platform technology, SDC is
distinguished from competitors in the marketplace because of its
superior efficacy, reduced toxicity and the inability of bacteria to
form a resistance to it. PURE is headquartered in El Cajon, California
(San Diego metropolitan area). Additional information on PURE is
available at www.purebio.com.
This press release includes statements that may constitute
"forward-looking" statements, usually containing the words "believe,"
"estimate," "project,” "expect" or similar expressions. These statements
are made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. Forward-looking statements
inherently involve risks and uncertainties that could cause actual
results to differ materially from the forward-looking statements.
Factors that would cause or contribute to such differences include, but
are not limited to, acceptance of the Company's current and future
products and services in the marketplace, the ability of the Company to
develop effective new products and receive regulatory approvals of such
products, competitive factors, dependence upon third-party vendors, and
other risks detailed in the Company's periodic report filings with the
Securities and Exchange Commission. By making these forward-looking
statements, the Company undertakes no obligation to update these
statements for revisions or changes after the date of this release.
Misco Products Corporation
Todd Northey, (800) 548-4568
tnorthey@emailmpc.com
or
PURE
Investor Contact:
Bibicoff + MacInnis, Inc.
Terri
MacInnis, Dir. of Investor Relations, (818) 379-8500
terri@bibimac.com
or
PURE
Media Contact:
Gutenberg Communications
Michael Gallo,
(212) 239-8594
mgallo@gutenbergpr.com